Award Synopsis IAVI.pdf
PDF 91 KB Posted
- Solicitation number
- 75N93019R00023
About this file
This award synopsis provides details of a contract awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to the International AIDS Vaccine Initiative for preclinical and translational vaccine development for HIV and other candidate agents. The contract number is 75N93022D00005 and has a period of performance from December 1, 2021 through November 30, 2028. The total estimated cost including all options is $364,553,934 under an indefinite delivery/indefinite quantity contract. The awardee will perform at its location in New York City. The solicitation number associated with the award was 75N93019R00023. The contract was awarded on December 1, 2021 to support research and development in preclinical and translational vaccine development for HIV and other infectious diseases.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AWARD SYNOPSIS
Type: Award
Date of Award: December 1, 2021
Period of Performance (including all options): December 1, 2021 through November 30, 2028
Title: "PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR
HIV AND OTHER CANDIDATE AGENTS”
(RFP) No.: 75N93019R00023
NAICS: 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Contract Number: 75N93022D00005
Total Estimated Cost (Including all Options): $364,553,934 maximum amount (IDIQ)
Place of Performance/Awardee:
International AIDS Vaccine Initiative (IAVI) 125 Broad Street, 9th Floor New York, NY 10004
DUNS: 020790895
Primary Point of Contact at NIAID: Kishan Patel Contracting Officer patelki@niaid.nih.gov mailto:patelki@niaid.nih.gov
File details come from the government source that posted it. Updated .